TY - JOUR
T1 - Characteristics of Vitamin B12 Deficiency in Patients With Plasma Cell Disorders
AU - Braschi, Caitlyn
AU - Doucette, John
AU - Chari, Ajai
N1 - Publisher Copyright:
© 2017 Elsevier Inc.
PY - 2017/12
Y1 - 2017/12
N2 - Micro-Abstract Vitamin B12 deficiency is prevalent among patients with plasma cell dyscrasias (PCDs), but the association is poorly understood. Among 501 patients with PCDs, 20% had low B12. Low B12 was more prevalent in patients with preserved renal function. Mean corpuscular volume was not clinically different between patients with low and normal B12 and may not be reliable in PCDs. Background Although increased rates of vitamin B12 deficiency have been reported in patients with plasma cell dyscrasias (PCDs), no mechanism has been identified. Excess free light chains (FLCs) could disrupt the renal proximal tubule receptors where B12 is reabsorbed. We sought to characterize the relationship between B12 deficiency and PCDs. We hypothesized that rates of B12 deficiency would be highest in patients with PCDs with high FLC burdens. Methods We reviewed the electronic medical records of 501 patients who met inclusion criteria (diagnosed PCD with documented serum B12 and FLC levels) to obtain clinical data recorded prior to patients' lowest B12 levels. Results Overall, 20.0% of patients had low vitamin B12. There was an expected negative correlation between estimated glomular filtration rate and FLC (rs = −0.317; P <.001). However, low B12 levels were more prevalent in patients with preserved renal function (P =.047). Low B12 was associated with lower mean corpuscular volume (P =.037). Conclusion Higher FLC burden was associated with poor kidney function but not with low B12. Low B12 was seen more commonly in patients with preserved kidney function. Mean corpuscular volume was statistically but not clinically different between patients with low and normal B12 and, therefore, may not be a reliable indicator of B12 deficiency in PCDs. Prospective studies should compare B12 metabolites with FLC levels. Detection of B12 deficiency among patients with PCDs remains important to reduce neurologic dysfunction and cytopenias, sequelae common to B12 deficiency and PCDs.
AB - Micro-Abstract Vitamin B12 deficiency is prevalent among patients with plasma cell dyscrasias (PCDs), but the association is poorly understood. Among 501 patients with PCDs, 20% had low B12. Low B12 was more prevalent in patients with preserved renal function. Mean corpuscular volume was not clinically different between patients with low and normal B12 and may not be reliable in PCDs. Background Although increased rates of vitamin B12 deficiency have been reported in patients with plasma cell dyscrasias (PCDs), no mechanism has been identified. Excess free light chains (FLCs) could disrupt the renal proximal tubule receptors where B12 is reabsorbed. We sought to characterize the relationship between B12 deficiency and PCDs. We hypothesized that rates of B12 deficiency would be highest in patients with PCDs with high FLC burdens. Methods We reviewed the electronic medical records of 501 patients who met inclusion criteria (diagnosed PCD with documented serum B12 and FLC levels) to obtain clinical data recorded prior to patients' lowest B12 levels. Results Overall, 20.0% of patients had low vitamin B12. There was an expected negative correlation between estimated glomular filtration rate and FLC (rs = −0.317; P <.001). However, low B12 levels were more prevalent in patients with preserved renal function (P =.047). Low B12 was associated with lower mean corpuscular volume (P =.037). Conclusion Higher FLC burden was associated with poor kidney function but not with low B12. Low B12 was seen more commonly in patients with preserved kidney function. Mean corpuscular volume was statistically but not clinically different between patients with low and normal B12 and, therefore, may not be a reliable indicator of B12 deficiency in PCDs. Prospective studies should compare B12 metabolites with FLC levels. Detection of B12 deficiency among patients with PCDs remains important to reduce neurologic dysfunction and cytopenias, sequelae common to B12 deficiency and PCDs.
KW - Cobalamin
KW - Immunoglobulin light chains
KW - Multiple myeloma
KW - Paraproteinemias
KW - Renal failure
UR - http://www.scopus.com/inward/record.url?scp=85026303665&partnerID=8YFLogxK
U2 - 10.1016/j.clml.2017.07.001
DO - 10.1016/j.clml.2017.07.001
M3 - Article
C2 - 28757000
AN - SCOPUS:85026303665
SN - 2152-2650
VL - 17
SP - e65-e69
JO - Clinical Lymphoma, Myeloma and Leukemia
JF - Clinical Lymphoma, Myeloma and Leukemia
IS - 12
ER -